Market Research Assistance

On the Web
Refine Result

By Date

Last Month
Last 3 Months
Last 6 Months
Last Year
Last 2 Years

By Price

< $1000
$1000-$2500
$2501-$4000
$4001-$5500
$5501-$7500
$7501-$9000
>$9000

Hypertension Drugs Market Research Reports

Titlepublishedprice

Idiopathic (Essential) Hypertension-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

By Delve Insight
"...... iopathic (Essential) Hypertension Report is to understand the market and pipeline status of the drugs around the Idiopathic (Essential) Hypertension to explore the generic development opportunities, licensing opportunities and to gain competitive adv......"
01-Jan-2017$2000

Resistant Hypertension-Pipeline Insights, 2017

By Delve Insight
"...... re-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA......"
01-Jan-2017$1250

Idiopathic (Essential) Hypertension-Pipeline Insights, 2017

By Delve Insight
"...... ent including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundin......"
01-Jan-2017$1250

Remodulin -Drug Insights, 2017

By Delve Insight
"...... provides the Remodulin sales performance during the historical period and forecast period to 2018. DelveInsight's Report also covers the detailed clinical assessment of Remodulin, patents information and exclusivity data, route of synthesis, competi......"
01-Jan-2017$1000

Pulmonary Arterial Hypertension (PAH) - Market Insights, Epidemiology and Market Forecast-2023

By Delve Insight
"...... y, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Pulmonary Arterial Hypertension (PAH) forecasted market share for ten years to 2023 segmented by seven major markets. In addit......"
01-Jan-2017$4950

Systolic Hypertension-Pipeline Insights, 2017

By Delve Insight
"...... -clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA d......"
01-Jan-2017$1250

Pulmonary Arterial Hypertension-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

By Delve Insight
"...... ary Arterial Hypertension Report is to understand the market and pipeline status of the drugs around the Pulmonary Arterial Hypertension to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on de......"
01-Jan-2017$2000

Tekturna -Drug Insights, 2017

By Delve Insight
"...... ovides the Tekturna sales performance during the historical period and forecast period to 2018. DelveInsight's Report also covers the detailed clinical assessment of Tekturna, patents information and exclusivity data, route of synthesis, competitive ......"
01-Jan-2017$1000

Tracleer -Drug Insights, 2017

By Delve Insight
"...... ovides the Tracleer sales performance during the historical period and forecast period to 2018. DelveInsight's Report also covers the detailed clinical assessment of Tracleer, patents information and exclusivity data, route of synthesis, competitive ......"
01-Jan-2017$1000

Tribenzor -Drug Insights, 2017

By Delve Insight
"...... provides the Tribenzor sales performance during the historical period and forecast period to 2018. DelveInsight's Report also covers the detailed clinical assessment of Tribenzor, patents information and exclusivity data, route of synthesis, competi......"
01-Jan-2017$1000

Avail upto 50% Discount on below Publisher Reports.